Trial Profile
An Exploratory Study to Evaluate the Distribution of [111In]ABY-025 Uptake for SPECT Imaging in Subjects With Metastatic Breast Cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Anti HER2 small molecule imaging agent (Primary)
- Indications Breast cancer
- Focus Diagnostic use; First in man
- 19 May 2014 New trial record